Versed

ApprovedSmall molecule

EEmory University

Versed is one of 53 small molecule programs targeting Ventricular Tachycardia. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ventricular TachycardiaActive, not recruiting

Opioid Use DisorderActive, not recruiting

Ventricular TachycardiaPreclinical

Active, not recruiting

Opioid Use DisorderApproved

Active, not recruiting

Competition

Competitive Landscape

116 competitors in Opioid Use Disorder

#DrugCompanyPhaseTrials

Revia

Teva

Phase 3

2 2

Belsomra

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 3

4 3

Epidiolex

Jazz Pharmaceuticals

Phase 2

5 4

Dayvigo

Eisai

Phase 2

2 5

Ozempic

Novo Nordisk

Phase 2

1 6

Vraylar

AbbVie

Phase 2

1 7

Mounjaro

Eli Lilly

Phase 2

1 8

Victoza

Novo Nordisk

Phase 2

1 9

Diamox

Teva

Phase 2

—10

Buprenorphine/naloxone

Astellas

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ventricular Tachycardia1 trial

Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia

Completed·—·N/A·NCT02419547·11 enrolled

Opioid Use Disorder1 trial

PROUD Study - Preventing Opioid Use Disorders

Terminated·EEmory University·Phase 4·NCT04766996·57 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Versed. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Versed compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Versed. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Emory University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: EEmory University

Versed

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Ventricular Tachycardia1 trial

Opioid Use Disorder1 trial

References

Drug Info

Quick Facts

Related News